mTOR activity is upregulated in renal cyst lining epithelial cells in patient with ADPKD, suggesting a potential benefit of mTOR inhibitor treatment in reducing renal and hepatic cyst growth. The gene discussed is MTOR; the disease is autosomal dominant polycystic kidney disease.